In the present study, we aimed to better characterize the tumor-promoting actions of the IR-A vis a vis the IR-B in TNBC cells in response to insulin, and identify IR-A-specific gene profiles, which might reveal novel therapeutic approaches. This evidence concerns the gene INS and neoplasm.